Global Hyperimmune Globulins Supply, Demand and Key Producers, 2024-2030

Description

The global Hyperimmune Globulins market size is expected to reach $ 2742.7 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

This report studies the global Hyperimmune Globulins production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hyperimmune Globulins, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperimmune Globulins that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hyperimmune Globulins total production and demand, 2019-2030, (K Units)
Global Hyperimmune Globulins total production value, 2019-2030, (USD Million)
Global Hyperimmune Globulins production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Hyperimmune Globulins consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Hyperimmune Globulins domestic production, consumption, key domestic manufacturers and share
Global Hyperimmune Globulins production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Hyperimmune Globulins production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Hyperimmune Globulins production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Hyperimmune Globulins market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperimmune Globulins market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hyperimmune Globulins Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hyperimmune Globulins Market, Segmentation by Type
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Rho(D) Immunoglobulins
    Other

Global Hyperimmune Globulins Market, Segmentation by Application
    Government Institutions
    Private Sector
    Other

Companies Profiled:
    CSL Behring
    Grifols
    Biotest
    Kedrion
    CBPO
    Emergent (Cangene)
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    ADMA Biologics

Key Questions Answered
1. How big is the global Hyperimmune Globulins market?
2. What is the demand of the global Hyperimmune Globulins market?
3. What is the year over year growth of the global Hyperimmune Globulins market?
4. What is the production and production value of the global Hyperimmune Globulins market?
5. Who are the key producers in the global Hyperimmune Globulins market?

Table of Contents

1 Supply Summary
    1.1 Hyperimmune Globulins Introduction
    1.2 World Hyperimmune Globulins Supply & Forecast
        1.2.1 World Hyperimmune Globulins Production Value (2019 & 2023 & 2030)
        1.2.2 World Hyperimmune Globulins Production (2019-2030)
        1.2.3 World Hyperimmune Globulins Pricing Trends (2019-2030)
    1.3 World Hyperimmune Globulins Production by Region (Based on Production Site)
        1.3.1 World Hyperimmune Globulins Production Value by Region (2019-2030)
        1.3.2 World Hyperimmune Globulins Production by Region (2019-2030)
        1.3.3 World Hyperimmune Globulins Average Price by Region (2019-2030)
        1.3.4 North America Hyperimmune Globulins Production (2019-2030)
        1.3.5 Europe Hyperimmune Globulins Production (2019-2030)
        1.3.6 China Hyperimmune Globulins Production (2019-2030)
        1.3.7 Japan Hyperimmune Globulins Production (2019-2030)
        1.3.8 Australia Hyperimmune Globulins Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hyperimmune Globulins Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hyperimmune Globulins Major Market Trends

2 Demand Summary
    2.1 World Hyperimmune Globulins Demand (2019-2030)
    2.2 World Hyperimmune Globulins Consumption by Region
        2.2.1 World Hyperimmune Globulins Consumption by Region (2019-2024)
        2.2.2 World Hyperimmune Globulins Consumption Forecast by Region (2025-2030)
    2.3 United States Hyperimmune Globulins Consumption (2019-2030)
    2.4 China Hyperimmune Globulins Consumption (2019-2030)
    2.5 Europe Hyperimmune Globulins Consumption (2019-2030)
    2.6 Japan Hyperimmune Globulins Consumption (2019-2030)
    2.7 South Korea Hyperimmune Globulins Consumption (2019-2030)
    2.8 ASEAN Hyperimmune Globulins Consumption (2019-2030)
    2.9 India Hyperimmune Globulins Consumption (2019-2030)

3 World Hyperimmune Globulins Manufacturers Competitive Analysis
    3.1 World Hyperimmune Globulins Production Value by Manufacturer (2019-2024)
    3.2 World Hyperimmune Globulins Production by Manufacturer (2019-2024)
    3.3 World Hyperimmune Globulins Average Price by Manufacturer (2019-2024)
    3.4 Hyperimmune Globulins Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Hyperimmune Globulins Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Hyperimmune Globulins in 2023
        3.5.3 Global Concentration Ratios (CR8) for Hyperimmune Globulins in 2023
    3.6 Hyperimmune Globulins Market: Overall Company Footprint Analysis
        3.6.1 Hyperimmune Globulins Market: Region Footprint
        3.6.2 Hyperimmune Globulins Market: Company Product Type Footprint
        3.6.3 Hyperimmune Globulins Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Hyperimmune Globulins Production Value Comparison
        4.1.1 United States VS China: Hyperimmune Globulins Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Hyperimmune Globulins Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Hyperimmune Globulins Production Comparison
        4.2.1 United States VS China: Hyperimmune Globulins Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hyperimmune Globulins Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Hyperimmune Globulins Consumption Comparison
        4.3.1 United States VS China: Hyperimmune Globulins Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Hyperimmune Globulins Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Hyperimmune Globulins Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Hyperimmune Globulins Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Hyperimmune Globulins Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Hyperimmune Globulins Production (2019-2024)
    4.5 China Based Hyperimmune Globulins Manufacturers and Market Share
        4.5.1 China Based Hyperimmune Globulins Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Hyperimmune Globulins Production Value (2019-2024)
        4.5.3 China Based Manufacturers Hyperimmune Globulins Production (2019-2024)
    4.6 Rest of World Based Hyperimmune Globulins Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Hyperimmune Globulins Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Hyperimmune Globulins Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Hyperimmune Globulins Production (2019-2024)

5 Market Analysis by Type
    5.1 World Hyperimmune Globulins Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Hepatitis B Immunoglobulins
        5.2.2 Rabies Immunoglobulins
        5.2.3 Tetanus Immunoglobulins
        5.2.4 Rho(D) Immunoglobulins
        5.2.5 Other
    5.3 Market Segment by Type
        5.3.1 World Hyperimmune Globulins Production by Type (2019-2030)
        5.3.2 World Hyperimmune Globulins Production Value by Type (2019-2030)
        5.3.3 World Hyperimmune Globulins Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Hyperimmune Globulins Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Government Institutions
        6.2.2 Private Sector
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Hyperimmune Globulins Production by Application (2019-2030)
        6.3.2 World Hyperimmune Globulins Production Value by Application (2019-2030)
        6.3.3 World Hyperimmune Globulins Average Price by Application (2019-2030)

7 Company Profiles
    7.1 CSL Behring
        7.1.1 CSL Behring Details
        7.1.2 CSL Behring Major Business
        7.1.3 CSL Behring Hyperimmune Globulins Product and Services
        7.1.4 CSL Behring Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 CSL Behring Recent Developments/Updates
        7.1.6 CSL Behring Competitive Strengths & Weaknesses
    7.2 Grifols
        7.2.1 Grifols Details
        7.2.2 Grifols Major Business
        7.2.3 Grifols Hyperimmune Globulins Product and Services
        7.2.4 Grifols Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Grifols Recent Developments/Updates
        7.2.6 Grifols Competitive Strengths & Weaknesses
    7.3 Biotest
        7.3.1 Biotest Details
        7.3.2 Biotest Major Business
        7.3.3 Biotest Hyperimmune Globulins Product and Services
        7.3.4 Biotest Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Biotest Recent Developments/Updates
        7.3.6 Biotest Competitive Strengths & Weaknesses
    7.4 Kedrion
        7.4.1 Kedrion Details
        7.4.2 Kedrion Major Business
        7.4.3 Kedrion Hyperimmune Globulins Product and Services
        7.4.4 Kedrion Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Kedrion Recent Developments/Updates
        7.4.6 Kedrion Competitive Strengths & Weaknesses
    7.5 CBPO
        7.5.1 CBPO Details
        7.5.2 CBPO Major Business
        7.5.3 CBPO Hyperimmune Globulins Product and Services
        7.5.4 CBPO Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 CBPO Recent Developments/Updates
        7.5.6 CBPO Competitive Strengths & Weaknesses
    7.6 Emergent (Cangene)
        7.6.1 Emergent (Cangene) Details
        7.6.2 Emergent (Cangene) Major Business
        7.6.3 Emergent (Cangene) Hyperimmune Globulins Product and Services
        7.6.4 Emergent (Cangene) Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Emergent (Cangene) Recent Developments/Updates
        7.6.6 Emergent (Cangene) Competitive Strengths & Weaknesses
    7.7 Kamada
        7.7.1 Kamada Details
        7.7.2 Kamada Major Business
        7.7.3 Kamada Hyperimmune Globulins Product and Services
        7.7.4 Kamada Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Kamada Recent Developments/Updates
        7.7.6 Kamada Competitive Strengths & Weaknesses
    7.8 CNBG
        7.8.1 CNBG Details
        7.8.2 CNBG Major Business
        7.8.3 CNBG Hyperimmune Globulins Product and Services
        7.8.4 CNBG Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 CNBG Recent Developments/Updates
        7.8.6 CNBG Competitive Strengths & Weaknesses
    7.9 Hualan Bio
        7.9.1 Hualan Bio Details
        7.9.2 Hualan Bio Major Business
        7.9.3 Hualan Bio Hyperimmune Globulins Product and Services
        7.9.4 Hualan Bio Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Hualan Bio Recent Developments/Updates
        7.9.6 Hualan Bio Competitive Strengths & Weaknesses
    7.10 Shanghai RAAS
        7.10.1 Shanghai RAAS Details
        7.10.2 Shanghai RAAS Major Business
        7.10.3 Shanghai RAAS Hyperimmune Globulins Product and Services
        7.10.4 Shanghai RAAS Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Shanghai RAAS Recent Developments/Updates
        7.10.6 Shanghai RAAS Competitive Strengths & Weaknesses
    7.11 Sichuan Yuanda Shuyang
        7.11.1 Sichuan Yuanda Shuyang Details
        7.11.2 Sichuan Yuanda Shuyang Major Business
        7.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Product and Services
        7.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
        7.11.6 Sichuan Yuanda Shuyang Competitive Strengths & Weaknesses
    7.12 ADMA Biologics
        7.12.1 ADMA Biologics Details
        7.12.2 ADMA Biologics Major Business
        7.12.3 ADMA Biologics Hyperimmune Globulins Product and Services
        7.12.4 ADMA Biologics Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 ADMA Biologics Recent Developments/Updates
        7.12.6 ADMA Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hyperimmune Globulins Industry Chain
    8.2 Hyperimmune Globulins Upstream Analysis
        8.2.1 Hyperimmune Globulins Core Raw Materials
        8.2.2 Main Manufacturers of Hyperimmune Globulins Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Hyperimmune Globulins Production Mode
    8.6 Hyperimmune Globulins Procurement Model
    8.7 Hyperimmune Globulins Industry Sales Model and Sales Channels
        8.7.1 Hyperimmune Globulins Sales Model
        8.7.2 Hyperimmune Globulins Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hyperimmune Globulins Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Hyperimmune Globulins Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Hyperimmune Globulins Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Hyperimmune Globulins Production Value Market Share by Region (2019-2024)
    Table 5. World Hyperimmune Globulins Production Value Market Share by Region (2025-2030)
    Table 6. World Hyperimmune Globulins Production by Region (2019-2024) & (K Units)
    Table 7. World Hyperimmune Globulins Production by Region (2025-2030) & (K Units)
    Table 8. World Hyperimmune Globulins Production Market Share by Region (2019-2024)
    Table 9. World Hyperimmune Globulins Production Market Share by Region (2025-2030)
    Table 10. World Hyperimmune Globulins Average Price by Region (2019-2024) & (USD/Unit)
    Table 11. World Hyperimmune Globulins Average Price by Region (2025-2030) & (USD/Unit)
    Table 12. Hyperimmune Globulins Major Market Trends
    Table 13. World Hyperimmune Globulins Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Hyperimmune Globulins Consumption by Region (2019-2024) & (K Units)
    Table 15. World Hyperimmune Globulins Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Hyperimmune Globulins Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Hyperimmune Globulins Producers in 2023
    Table 18. World Hyperimmune Globulins Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Hyperimmune Globulins Producers in 2023
    Table 20. World Hyperimmune Globulins Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 21. Global Hyperimmune Globulins Company Evaluation Quadrant
    Table 22. World Hyperimmune Globulins Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Hyperimmune Globulins Production Site of Key Manufacturer
    Table 24. Hyperimmune Globulins Market: Company Product Type Footprint
    Table 25. Hyperimmune Globulins Market: Company Product Application Footprint
    Table 26. Hyperimmune Globulins Competitive Factors
    Table 27. Hyperimmune Globulins New Entrant and Capacity Expansion Plans
    Table 28. Hyperimmune Globulins Mergers & Acquisitions Activity
    Table 29. United States VS China Hyperimmune Globulins Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Hyperimmune Globulins Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Hyperimmune Globulins Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Hyperimmune Globulins Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Hyperimmune Globulins Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Hyperimmune Globulins Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Hyperimmune Globulins Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Hyperimmune Globulins Production Market Share (2019-2024)
    Table 37. China Based Hyperimmune Globulins Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Hyperimmune Globulins Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Hyperimmune Globulins Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Hyperimmune Globulins Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Hyperimmune Globulins Production Market Share (2019-2024)
    Table 42. Rest of World Based Hyperimmune Globulins Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Hyperimmune Globulins Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Hyperimmune Globulins Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Hyperimmune Globulins Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Hyperimmune Globulins Production Market Share (2019-2024)
    Table 47. World Hyperimmune Globulins Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Hyperimmune Globulins Production by Type (2019-2024) & (K Units)
    Table 49. World Hyperimmune Globulins Production by Type (2025-2030) & (K Units)
    Table 50. World Hyperimmune Globulins Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Hyperimmune Globulins Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Hyperimmune Globulins Average Price by Type (2019-2024) & (USD/Unit)
    Table 53. World Hyperimmune Globulins Average Price by Type (2025-2030) & (USD/Unit)
    Table 54. World Hyperimmune Globulins Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Hyperimmune Globulins Production by Application (2019-2024) & (K Units)
    Table 56. World Hyperimmune Globulins Production by Application (2025-2030) & (K Units)
    Table 57. World Hyperimmune Globulins Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Hyperimmune Globulins Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Hyperimmune Globulins Average Price by Application (2019-2024) & (USD/Unit)
    Table 60. World Hyperimmune Globulins Average Price by Application (2025-2030) & (USD/Unit)
    Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 62. CSL Behring Major Business
    Table 63. CSL Behring Hyperimmune Globulins Product and Services
    Table 64. CSL Behring Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. CSL Behring Recent Developments/Updates
    Table 66. CSL Behring Competitive Strengths & Weaknesses
    Table 67. Grifols Basic Information, Manufacturing Base and Competitors
    Table 68. Grifols Major Business
    Table 69. Grifols Hyperimmune Globulins Product and Services
    Table 70. Grifols Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Grifols Recent Developments/Updates
    Table 72. Grifols Competitive Strengths & Weaknesses
    Table 73. Biotest Basic Information, Manufacturing Base and Competitors
    Table 74. Biotest Major Business
    Table 75. Biotest Hyperimmune Globulins Product and Services
    Table 76. Biotest Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Biotest Recent Developments/Updates
    Table 78. Biotest Competitive Strengths & Weaknesses
    Table 79. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 80. Kedrion Major Business
    Table 81. Kedrion Hyperimmune Globulins Product and Services
    Table 82. Kedrion Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Kedrion Recent Developments/Updates
    Table 84. Kedrion Competitive Strengths & Weaknesses
    Table 85. CBPO Basic Information, Manufacturing Base and Competitors
    Table 86. CBPO Major Business
    Table 87. CBPO Hyperimmune Globulins Product and Services
    Table 88. CBPO Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. CBPO Recent Developments/Updates
    Table 90. CBPO Competitive Strengths & Weaknesses
    Table 91. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
    Table 92. Emergent (Cangene) Major Business
    Table 93. Emergent (Cangene) Hyperimmune Globulins Product and Services
    Table 94. Emergent (Cangene) Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Emergent (Cangene) Recent Developments/Updates
    Table 96. Emergent (Cangene) Competitive Strengths & Weaknesses
    Table 97. Kamada Basic Information, Manufacturing Base and Competitors
    Table 98. Kamada Major Business
    Table 99. Kamada Hyperimmune Globulins Product and Services
    Table 100. Kamada Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Kamada Recent Developments/Updates
    Table 102. Kamada Competitive Strengths & Weaknesses
    Table 103. CNBG Basic Information, Manufacturing Base and Competitors
    Table 104. CNBG Major Business
    Table 105. CNBG Hyperimmune Globulins Product and Services
    Table 106. CNBG Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. CNBG Recent Developments/Updates
    Table 108. CNBG Competitive Strengths & Weaknesses
    Table 109. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 110. Hualan Bio Major Business
    Table 111. Hualan Bio Hyperimmune Globulins Product and Services
    Table 112. Hualan Bio Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Hualan Bio Recent Developments/Updates
    Table 114. Hualan Bio Competitive Strengths & Weaknesses
    Table 115. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 116. Shanghai RAAS Major Business
    Table 117. Shanghai RAAS Hyperimmune Globulins Product and Services
    Table 118. Shanghai RAAS Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Shanghai RAAS Recent Developments/Updates
    Table 120. Shanghai RAAS Competitive Strengths & Weaknesses
    Table 121. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
    Table 122. Sichuan Yuanda Shuyang Major Business
    Table 123. Sichuan Yuanda Shuyang Hyperimmune Globulins Product and Services
    Table 124. Sichuan Yuanda Shuyang Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Sichuan Yuanda Shuyang Recent Developments/Updates
    Table 126. ADMA Biologics Basic Information, Manufacturing Base and Competitors
    Table 127. ADMA Biologics Major Business
    Table 128. ADMA Biologics Hyperimmune Globulins Product and Services
    Table 129. ADMA Biologics Hyperimmune Globulins Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 130. Global Key Players of Hyperimmune Globulins Upstream (Raw Materials)
    Table 131. Hyperimmune Globulins Typical Customers
    Table 132. Hyperimmune Globulins Typical Distributors
List of Figure
    Figure 1. Hyperimmune Globulins Picture
    Figure 2. World Hyperimmune Globulins Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Hyperimmune Globulins Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Hyperimmune Globulins Production (2019-2030) & (K Units)
    Figure 5. World Hyperimmune Globulins Average Price (2019-2030) & (USD/Unit)
    Figure 6. World Hyperimmune Globulins Production Value Market Share by Region (2019-2030)
    Figure 7. World Hyperimmune Globulins Production Market Share by Region (2019-2030)
    Figure 8. North America Hyperimmune Globulins Production (2019-2030) & (K Units)
    Figure 9. Europe Hyperimmune Globulins Production (2019-2030) & (K Units)
    Figure 10. China Hyperimmune Globulins Production (2019-2030) & (K Units)
    Figure 11. Japan Hyperimmune Globulins Production (2019-2030) & (K Units)
    Figure 12. Australia Hyperimmune Globulins Production (2019-2030) & (K Units)
    Figure 13. Hyperimmune Globulins Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 16. World Hyperimmune Globulins Consumption Market Share by Region (2019-2030)
    Figure 17. United States Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 18. China Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 19. Europe Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 20. Japan Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 21. South Korea Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 22. ASEAN Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 23. India Hyperimmune Globulins Consumption (2019-2030) & (K Units)
    Figure 24. Producer Shipments of Hyperimmune Globulins by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Hyperimmune Globulins Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Hyperimmune Globulins Markets in 2023
    Figure 27. United States VS China: Hyperimmune Globulins Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Hyperimmune Globulins Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States VS China: Hyperimmune Globulins Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 30. United States Based Manufacturers Hyperimmune Globulins Production Market Share 2023
    Figure 31. China Based Manufacturers Hyperimmune Globulins Production Market Share 2023
    Figure 32. Rest of World Based Manufacturers Hyperimmune Globulins Production Market Share 2023
    Figure 33. World Hyperimmune Globulins Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 34. World Hyperimmune Globulins Production Value Market Share by Type in 2023
    Figure 35. Hepatitis B Immunoglobulins
    Figure 36. Rabies Immunoglobulins
    Figure 37. Tetanus Immunoglobulins
    Figure 38. Rho(D) Immunoglobulins
    Figure 39. Other
    Figure 40. World Hyperimmune Globulins Production Market Share by Type (2019-2030)
    Figure 41. World Hyperimmune Globulins Production Value Market Share by Type (2019-2030)
    Figure 42. World Hyperimmune Globulins Average Price by Type (2019-2030) & (USD/Unit)
    Figure 43. World Hyperimmune Globulins Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 44. World Hyperimmune Globulins Production Value Market Share by Application in 2023
    Figure 45. Government Institutions
    Figure 46. Private Sector
    Figure 47. Other
    Figure 48. World Hyperimmune Globulins Production Market Share by Application (2019-2030)
    Figure 49. World Hyperimmune Globulins Production Value Market Share by Application (2019-2030)
    Figure 50. World Hyperimmune Globulins Average Price by Application (2019-2030) & (USD/Unit)
    Figure 51. Hyperimmune Globulins Industry Chain
    Figure 52. Hyperimmune Globulins Procurement Model
    Figure 53. Hyperimmune Globulins Sales Model
    Figure 54. Hyperimmune Globulins Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics